Skip to content
★ Sign in to follow
1H

160 Health International Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$1.2BHealth Care
Insider Decl.
14
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€8M
5 ops. · all time

Who traded when

BuySale
Huang Lang2 sales
Wang Lifa2 sales
Luo Ningzheng1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 24,916 of 26,911 companies
18.7
score / 100
Value
19
Quality
19
FCF yld-9.7%
Earn yld-6.0%
EV/EBITDA·
ROE-79%
Gross mgn26%
Net mgn-11%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$3.32
Analyst consensus
·
Income statement
RevenueHK$651.9M
Gross profitHK$170.2M26% margin
EBITDA-HK$64.6M-10% margin
Net income-HK$73M-7.6% margin
Valuation
P/Book4.0x
Balance sheet & cash
Market capHK$1.2B
Total debtHK$249.9M
Free Cash Flow-HK$118.6M
Debt / Equity149%
Profitability & ownership
ROE-78.5%
ROA-5.4%
% insiders38.3%
% institutions11.0%
Last declaration on 30 October 2026
Declarations14 total
  • ●
    DirectorExecutives
    0HKEX
    138,000 sharesShareXHKGHKEX:DA20261029E00474
  • ●
    DirectorExecutives
    0HKEX
    61,715 sharesShareXHKGHKEX:DA20261030E00303
  • ▼
    DirectorExecutives
    1M HKD32HKEX
    272,000 shares@ HK$4.6564.8% of flowShareXHKGHKEX:DA20260928E00024
  • ▼
    DirectorExecutives
    54M HKD50HKEX
    10,968,750 shares@ HK$4.9666.16% mcap100.0% of flowShareXHKGHKEX:DA20260924E00549
  • ▼
    DirectorExecutives
    690,200 HKD39HKEX
    140,000 shares@ HK$4.930.078% mcap35.2% of flowShareXHKGHKEX:DA20260925E00093
  • ▼
    DirectorExecutives
    15M HKD32HKEX
    2,615,500 shares@ HK$5.681.68% mcap96.6% of flowShareXHKGHKEX:DA20260923E00362
  • ▼
    DirectorExecutives
    518,320 HKD16HKEX
    62,000 shares@ HK$8.360.059% mcap3.4% of flowShareXHKGHKEX:DA20260922E00498
  • ●
    DirectorExecutives
    0HKEX
    800,000 sharesShareXHKGHKEX:DA20260302E00325
  • ●
    DirectorExecutives
    0HKEX
    3,139,490 sharesShareXHKGHKEX:DA20260302E00323
  • ●
    DirectorExecutives
    0HKEX
    114,639,570 sharesShareXHKGHKEX:DA20251002E00034
  • ●
    DirectorExecutives
    0HKEX
    550,000 sharesShareXHKGHKEX:DA20251002E00045
  • ●
    DirectorExecutives
    0HKEX
    3,139,490 sharesShareXHKGHKEX:DA20251002E00039
  • ●
    DirectorExecutives
    0HKEX
    3,115,000 sharesShareXHKGHKEX:DA20251002E00043
  • ●
    DirectorExecutives
    0HKEX
    3,115,000 sharesShareXHKGHKEX:DA20251002E00042

14 of 14 declarations

About 160 Health International Ltd.

Five sales filed by directors of 160 Health International Ltd., a health care company listed in Hong Kong and valued at HKD 817.8 million, total EUR 7,967,595, with a median of EUR 140,873, and no purchase appears in the record. The largest, EUR 6,043,537, is by Luo Ningzheng (Director) on September 21, 2026. Next come EUR 1,648,872 for Huang Lang (Director) on September 18, 2026, and EUR 140,873 for Wang Lifa (Director) on September 23, 2026.

The record holds 12 filings published from October 2, 2025 to September 28, 2026, 7 of them of another kind. Wang Lifa and Huang Lang have 3 filings each, 2 of them sales; Luo Ningzheng 2 filings, 1 of them a sale; Zhang Ruxie 2 filings and Liu Haibin 1, with neither purchase nor sale. Directors and other insiders hold 38.3% of the capital.

Read moreShow less

5 filings date from 2025 and 7 from 2026, and those 7 are also the last twelve months. The publication delay is 6 days at the median.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations